For example, NLRP3 inhibitor MCC950 has the potential to prevent NLRP3-related diseases, such as cardiac hypertrophy (68), hypertension (69), atherosclerosis (70), and myocardial injury (71). This evidence concerns the gene NLRP3 and cardiac hypertrophy.